267 related articles for article (PubMed ID: 34478740)
1. Molecular alterations in retinoblastoma beyond RB1.
Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
[TBL] [Abstract][Full Text] [Related]
3. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
[TBL] [Abstract][Full Text] [Related]
4. Mutational screening of germline
Nguyen HH; Nguyen HTT; Vu NP; Le QT; Pham CM; Huyen TT; Manh H; Pham HLB; Nguyen TD; Le HTT; Van Nong H
Mol Vis; 2018; 24():231-238. PubMed ID: 29568217
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of mutations in the
Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous identification of clinically relevant
Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
[TBL] [Abstract][Full Text] [Related]
9.
Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL
Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019
[No Abstract] [Full Text] [Related]
10.
Price EA; Patel R; Scheimberg I; Kotiloglu Karaa E; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2021 Oct; 42(5):604-611. PubMed ID: 34003079
[No Abstract] [Full Text] [Related]
11. Multiplex ligation-dependent probe amplification versus fluorescent in situ hybridization for screening
Eid OM; El Zomor H; Mohamed AM; El-Bassyouni HT; Afifi HH; El-Ayadi M; Sadek SH; Hammad SA; Salem SI; Mahrous R; Fadel IM; Refaat K; Afifi MA; Shelil AE; Ziko OAO; Abdel Azeem AA; El-Haddad A
Ophthalmic Genet; 2022 Dec; 43(6):789-794. PubMed ID: 36098066
[TBL] [Abstract][Full Text] [Related]
12. A novel de-novo RB1 mutation identified in a patient with bilateral retinoblastoma.
Fukushima H; Suzuki R; Hiraoka T; Suzuki S; Noguchi E; Takada H
Jpn J Clin Oncol; 2023 Aug; 53(9):863-865. PubMed ID: 37345682
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort.
Singh J; Mishra A; Pandian AJ; Mallipatna AC; Khetan V; Sripriya S; Kapoor S; Agarwal S; Sankaran S; Katragadda S; Veeramachaneni V; Hariharan R; Subramanian K; Mannan AU
Mol Vis; 2016; 22():1036-47. PubMed ID: 27582626
[TBL] [Abstract][Full Text] [Related]
14. Uncommon RB1 somatic mutations in a unilateral retinoblastoma patient.
Ottaviani D; Alonso C; Szijan I
Medicina (B Aires); 2015; 75(3):137-41. PubMed ID: 26117602
[TBL] [Abstract][Full Text] [Related]
15. RB1 gene mutations and genetic spectrum in retinoblastoma cases.
Akdeniz Odemis D; Kebudi R; Bayramova J; Kilic Erciyas S; Kuru Turkcan G; Tuncer SB; Sukruoglu Erdogan O; Celik B; Kurt Gultaslar B; Buyukkapu Bay S; Tuncer S; Yazici H
Medicine (Baltimore); 2023 Sep; 102(36):e35068. PubMed ID: 37682130
[TBL] [Abstract][Full Text] [Related]
16. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
Price EA; Kolkiewicz K; Patel R; Hashim S; Karaa E; Scheimberg I; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2018 Aug; 39(4):526-531. PubMed ID: 29851531
[TBL] [Abstract][Full Text] [Related]
17. RB1 screening of retinoblastoma patients in Sri Lanka using targeted next generation sequencing (NGS) and gene ratio analysis copy enumeration PCR (GRACE-PCR).
Kugalingam N; De Silva D; Abeysekera H; Nanayakkara S; Tirimanne S; Ranaweera D; Suravajhala P; Chandrasekharan V
BMC Med Genomics; 2023 Nov; 16(1):279. PubMed ID: 37932687
[TBL] [Abstract][Full Text] [Related]
18. Genetics of Retinoblastoma.
Mallipatna A; Marino M; Singh AD
Asia Pac J Ophthalmol (Phila); 2016; 5(4):260-4. PubMed ID: 27488068
[TBL] [Abstract][Full Text] [Related]
19. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes.
Kooi IE; Mol BM; Massink MP; Ameziane N; Meijers-Heijboer H; Dommering CJ; van Mil SE; de Vries Y; van der Hout AH; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
Sci Rep; 2016 Apr; 6():25264. PubMed ID: 27126562
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
